UBS maintains 3M stock Buy rating with $184 target post-earnings

Published 23/04/2025, 15:00
UBS maintains 3M stock Buy rating with $184 target post-earnings

On Wednesday, UBS analyst Amit Mehrotra reaffirmed a Buy rating and a $184.00 price target for 3M stock, traded on the NYSE under the ticker (NYSE:MMM). With a current market capitalization of $76 billion and trading at $140.20, InvestingPro data shows the stock is fairly valued based on its proprietary Fair Value model. The stock has demonstrated strong momentum, delivering a remarkable 50% return over the past year. Following the company’s first-quarter results and subsequent discussions with 3M, Mehrotra increased his 2025 earnings per share (EPS) estimate to $8.00, up from $7.93. This revision positions his forecast above the consensus estimate of $7.73. The company currently trades at a P/E ratio of 17x and maintains a dividend yield of 2.14%, with its next earnings report scheduled for April 22, 2025.

Mehrotra highlighted that 3M’s reiterated earnings guidance of $7.60 to $7.90 is a positive signal. Additionally, he pointed out that the guidance now accounts for roughly a 10-cent contingency or cushion that was not previously included. The analyst also noted the potential for an additional 15-cent upside based on current foreign exchange rates. He suggested that recent currency movements since Liberation Day could negate a 15-cent headwind to 2025 EPS, according to UBS estimates. The company maintains a "FAIR" overall financial health score according to InvestingPro metrics, with particularly strong marks in profitability.

The UBS analyst observed signs of 3M regaining market share, as indicated by improvements in on-time and in-full delivery performance, order trends, and the organic growth outlook. Mehrotra’s assessment is that these factors, combined with revenue and cost opportunities, could drive further upside for 3M shares.

Mehrotra concluded by reiterating his positive stance on 3M stock, maintaining it as a Buy recommendation and a Top Pick within UBS’s coverage universe. The endorsement from UBS comes after a detailed analysis of 3M’s recent performance and forward-looking prospects, suggesting confidence in the company’s ability to surpass market expectations.

In other recent news, 3M Company reported a strong start to the fiscal year 2025, with a notable 10% increase in adjusted earnings per share (EPS) for the first quarter, reaching $1.88. The company’s organic sales grew by 1.5%, and operating margins improved by 220 basis points year-over-year. Despite a challenging macroeconomic environment, 3M demonstrated resilience by maintaining financial strength, returning $1.7 billion to shareholders, and raising its dividend by 4%. The company also launched 62 new products, marking a 60% increase from the previous year. Additionally, 3M plans to increase share repurchases to $2 billion, indicating confidence in its future cash flows and financial stability. The firm provided guidance for the full year, forecasting an EPS range of $7.60 to $7.90, while anticipating tariffs to impact EPS by approximately $0.40 to $0.60. Analysts from Vertical Research Partners and JPMorgan discussed 3M’s strategies for tariff mitigation and potential demand destruction, noting the company’s efforts to control costs and enhance sourcing and pricing strategies.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.